The claims arrive as a group, years after the last dose.
Cover for drug developers, manufacturers, compounders and distributors — a long-tail products exposure where claims aggregate and the recall is a regulated event.
Tell us the situation.
A licensed human replies the same business day — not an auto-responder, and not five producers calling at once. We shop it across our carriers and tell you if the policy you already have is the right one.
We use this to quote and service your insurance, and we do not sell it or pass it to lead networks. Privacy policy.
What pharmaceutical businesses actually need.
Products liability
Injury from a compound, including claims brought long after the exposure.
Without it — The defining exposure of the sector, and the slowest to emerge.
Product recall and withdrawal
Regulated recalls, market withdrawals and the destruction that follows.
Without it — A recall in this sector is a regulatory process with a fixed clock and real cost.
Clinical trial liability
The studies behind the submission.
Without it — No approval to run without it.
Contamination and cold chain
Batch contamination, and product spoiled in storage or transit.
Without it — A temperature excursion writes off a batch worth more than the shipment.
Directors and officers
Board exposure over disclosure, safety signals and regulatory communication.
Without it — The claims that follow a bad safety announcement are securities claims.
What pharmaceutical operators ask us.
What does “long tail” mean in practice for us?
That a claim can be made many years after the product was taken, so the policy in force TODAY may not be the one that answers. It makes two things matter more than the limit: whether cover is occurrence-based or claims-made, and continuity. On a claims-made program, a gap between policies or a lapsed retroactive date can strand years of exposure with nothing behind it. Never let cover lapse between insurers, and keep the retroactive date when you move.
We compound rather than manufacture. Is that different?
Different market, same core exposure, and often harder to place. Compounding pharmacies sit between pharmacy professional liability and pharmaceutical products liability, and sterile compounding in particular draws close underwriting scrutiny after the contamination events that reshaped the sector. Expect questions about USP compliance, sterility testing, batch records and whether you compound for office use or on prescription — the answers determine which market will look at you.
Do our contract manufacturers cover us?
Their policy covers them. You should be an additional insured on it and you should still carry your own, because the marketing authorisation holder is who patients and regulators pursue regardless of who ran the line. Relying on a CMO’s limits means relying on a limit shared with every other client they have, in a sector where one event affects a whole batch across all of them.
Not ready to talk? The guides answer the questions this page raises in more depth. Already insured with us and need a certificate or a policy change? Ask the service team rather than starting a quote — it is faster and it goes to the people whose job it is. We also write home and auto, which is usually cheaper alongside the business policy than apart from it.